Health
Astra’s Covid-19 vaccine woes deepen – Vantage
Denmark’s suspension of AZD1222 following blood clots heaps even more pressure on Astra’s US study.
Astrazeneca’s PR battle with its Covid-19 vaccine is intensifying. AZD1222 had already faced questions about its efficacy, and now safety is under the spotlight with the latest scare coming today from Denmark, which has suspended use of the jab as concerns about blood clots mount.
For countries contending with vaccine hesitancy this will be a blow. Even if AZD1222 is exonerated, reports like these will only make those who already have doubts even more reluctant to get a vaccine. For Astra specifically,…
-
Noosa News23 hours agoEnsure voices are heard – Proctor
-
General24 hours agoReserve Bank board still looking for yesterday’s news
-
Noosa News18 hours agoMajor crash on Gateway Motorway snarls morning commute
-
General23 hours agoMarkets live: ASX to slip after Reserve Bank’s surprise interest rate decision, Donald Trump announces further tariffs